[1]苑丽丽,张阳,樊琳琳,等.甲巯咪唑致粒细胞缺乏症2例[J].国际放射医学核医学杂志,2014,38(5):347-348,351.[doi:10.3760/cma.j.issn.1673-4114.2014.05.016]
点击复制

甲巯咪唑致粒细胞缺乏症2例(/HTML)
分享到:

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
38
期数:
2014年第5期
页码:
347-348,351
栏目:
出版日期:
2014-09-25

文章信息/Info

作者:
苑丽丽1 张阳2 樊琳琳3 黄承明1 谭建4
1. 山东省济宁市第一人民医院核医学科, 272000;
2. 山东省济宁市第一人民医院神经外科, 272000;
3. 山东省济宁市第一人民医院内分泌科, 272000;
4. 天津医科大学总医院核医学科, 300052
关键词:
甲巯咪唑抗甲状腺药粒细胞缺乏症
DOI:
10.3760/cma.j.issn.1673-4114.2014.05.016
摘要:
甲状腺功能亢进症(以下简称甲亢)最常见的病因是Graves病(以下简称GD)。

参考文献/References:

[1] Sun MT,Tsai CH,Shih KC.Antithyroid drug-induced agranulocytosis[J].J Chin Med Assoc,2009,72(8):438-441.
[2] Finucane FM,O’Connell J,Kinsley BT.Propylthiouracil induced C-ANCA positive agranulocytosis complicating Graves’ thyrotoxicosis in pregnancy[J].Ir J Med Sci,2008,177(1):69-71.
[3] Tsuboi K,Ueshiba H,Shimojo M,et al.The relation of initial methimazole dose to the incidence of methimazole-induced agranulocytosis in patients with Graves’ disease[J].Endocr J,2007,54(1):39-43.
[4] Tamai H,Sudo T,Kimura A,et al.Association between the DRB1*08032 histocompatibility antigen and methimazole-induced agranulocytosis in Japanese patients with Graves disease[J].Ann Intern Med,1996,124(5):490-494.
[5] Cooper DS,Goldminz D,Levin AA,et al.Agranulocytosis associated with antithyroid drugs.Effects of patient age and drug dose[J].Ann Intern Med,1983,98(1):26-29.
[6] Werner MC,Romaldini JH,Bromberg N,et al.Adverse effects related to thionamide drugs and their dose regimen[J].Am J Med Sci,1989,297(4):216-219.
[7] Bahn RS,Burch HB,Cooper DS,et al.Hyperthyroidism and other causes of thyrotoxicosis:Management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists[J].Endocr Pract,2011,17(3):456-520.
[8] Andrès E,Kurtz JE,Perrin AE,et al.Haematopoietic growth factor in antithyroid-drug-induced agranulocytosis[J].QJM,2001,94(8):423-428.
[9] Garbe E.Non-chemotherapy drug-induced agranulocytosis[J].Expert Opin Drug Saf,2007,6(3):323-335.
[10] Tamai H,Mukuta T,Matsubayashi S,et al.Treatment of methimazole-induced agranulocytosis using recombinant human granulocyte colony-stimulating factor(rhG-CSF)[J].J Clin Endocrinol Metab,1993,77(5):1356-1360.
[11] 徐丹,李路,袁凤易.抗甲状腺药物致粒细胞缺乏症 46 例临床分析[J].实用临床医学,2007,8(8):22-24.

相似文献/References:

[1]孟召伟,谭建.解读美国甲状腺协会和临床内分泌医师协会2011年甲亢诊治指南[J].国际放射医学核医学杂志,2011,35(4):193.[doi:10.3760/cma.j.issn.1673-4114.2011.04.001]
 MENG Zhao-wei,TAN Jian.Reading and analysis on management guidelines for hyperthyroidism published in 2011 by American Thyroid Association and American Association of Clinical Endocrinologists[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(5):193.[doi:10.3760/cma.j.issn.1673-4114.2011.04.001]
[2]王澎,谭建.不同药物影响Graves病131Ⅰ治疗效果的研究进展[J].国际放射医学核医学杂志,2011,35(1):9.[doi:10.3760/cma.j.issn.1673-4114.2011.01.003]
 WANG Peng,TAN Jian.Advance of study on the influence of different drugs on the efficacy of 131I treatment for Graves’ disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(5):9.[doi:10.3760/cma.j.issn.1673-4114.2011.01.003]
[3]王春梅,王雪梅.131I治疗甲亢的现状和研究进展[J].国际放射医学核医学杂志,2010,34(1):31.[doi:10.3760/cma.j.issn.1673-4114.2010.01.008]
 WANG Chun-mei,WANG Xue-mei.The development and current status of 131I treatment for hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(5):31.[doi:10.3760/cma.j.issn.1673-4114.2010.01.008]
[4]汤建林,李玉莹,高柳艳,等.甲状腺功能亢进症治疗方法的比较和选择[J].国际放射医学核医学杂志,2009,33(3):175.[doi:10.3760/cma.j.issn.1673-4114.2009.03.012]
 TANG Jian-lin,LI Yu-ying,GAO Liu-yan,et al.The methods and options of the treatment for hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(5):175.[doi:10.3760/cma.j.issn.1673-4114.2009.03.012]
[5]潘香颖,李慧贞.甲状腺功能亢进症伴肝功能受损的131I治疗疗效[J].国际放射医学核医学杂志,2009,33(3):179.[doi:10.3760/cma.j.issn.1673-4114.2009.03.013]
[6]苏莉,陈璟,赵明.131I治疗男性甲状腺亢进症周期性麻痹的临床观察:与抗甲状腺药物治疗比较[J].国际放射医学核医学杂志,2007,31(6):366.
 SU Li,CHEN Jing,ZHAO Ming.Clinical evaluation of the treatment in male patient with thyrotoxic periodic paralysis: 131I treatment compared with antithyroid drug therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(5):366.
[7]崔丽群,张承刚,李玲玲.小剂量131I治疗青少年Graves’病85例患者疗效观察[J].国际放射医学核医学杂志,2007,31(4):226.
 CUI Li-qun,ZHANG Cheng-gang,LI Ling-ling.The observation of curative effects by therapy with low-dose 131I in younger with Graves’ disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(5):226.
[8]陈丹云,静进.甲状腺功能亢进症治疗方法的选择[J].国际放射医学核医学杂志,2007,31(4):228.
 CHEN Dan-yun,JING Jin.Hyperthyroidism: a review of the treatment options[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(5):228.

备注/Memo

备注/Memo:
收稿日期:2014-06-04。
通讯作者:谭建(Email:tanpost@163.com)
更新日期/Last Update: 1900-01-01